BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7994046)

  • 1. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
    Clark SS; Liang Y; Reedstrom CK; Wu SQ
    Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes.
    Whitlock CA; Ziegler SF; Witte ON
    Mol Cell Biol; 1983 Apr; 3(4):596-604. PubMed ID: 6304498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.
    Whitlock CA; Witte ON
    J Virol; 1981 Nov; 40(2):577-84. PubMed ID: 6275106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased detection of specific tyrosine phosphoproteins correlates with tumor progression of Abelson virus-infected lymphocytes.
    Clark SS; Liang Y
    Leukemia; 1995 Jan; 9(1):165-74. PubMed ID: 7845013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
    Thome KC; Radfar A; Rosenberg N
    J Virol; 1997 Nov; 71(11):8149-56. PubMed ID: 9343165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
    Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
    Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.
    Poirier Y; Kozak C; Jolicoeur P
    J Virol; 1988 Nov; 62(11):3985-92. PubMed ID: 2845118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus.
    Noronha EJ; Sterling KH; Calame KL
    J Biol Chem; 2003 Dec; 278(51):50915-22. PubMed ID: 14559912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.
    Green PL; Kaehler DA; Risser R
    J Virol; 1987 Jul; 61(7):2192-7. PubMed ID: 3035219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.
    Young JC; Gishizky ML; Witte ON
    Mol Cell Biol; 1991 Feb; 11(2):854-63. PubMed ID: 1990288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.
    Clark SS; Chen E; Fizzotti M; Witte ON; Malkovska V
    J Virol; 1993 Oct; 67(10):6033-46. PubMed ID: 8396667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. v-abl causes hematopoietic disease distinct from that caused by bcr-abl.
    Scott ML; Van Etten RA; Daley GQ; Baltimore D
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6506-10. PubMed ID: 1862078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
    Jacobsen EA; Ananieva O; Brown ML; Chang Y
    J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.
    Rosenberg NE; Clark DR; Witte ON
    J Virol; 1980 Dec; 36(3):766-74. PubMed ID: 6257926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
    Sugiyama H; Wang Y; Jackson P; Sawyers CL; Klein G
    Int J Cancer; 1994 Jul; 58(1):135-41. PubMed ID: 8014009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
    J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.
    McLaughlin J; Chianese E; Witte ON
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6558-62. PubMed ID: 3498165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.